首頁 > 市場調查報告書 > 製藥

神經疾病

市場調查報告書

商品編碼

1449642

全球 Bracamesin 市場：按給藥途徑、按應用、按分銷管道、按地區

Global Blarcamesine Market, By Route of Adminsitration, By Application, By Distribution Channel, By Geography .

出版日期: 2024年02月16日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年，全球Bracamesin市場價值將達到8.222億美元，預計2031年將達到9.924億美元，2026年至2031年的年複合成長率為3.8%。

報告範圍		報告詳情
基準年	2023年	2023/2024年市場規模	8.222 億美元
實際資料	2019-2023	預測期	2026-2031
預測期間2023/2024 至2030/2031年年複合成長率：	3.80%	2030/2031價值預測	9.924 億美元

圖 1. Bracamesin全球市場佔有率（%），依地區分類，2026年

Blarcamesine 是細胞內 sigma-1Chaperone蛋白的促效劑。具體來說，它是混合的σ1/毒蕈鹼受體配體。 sigma 1受體在大多數組織中表達，位於粒線體和內質網之間的局部接觸處，與許多其他膜受體形成異二聚體，產生多種細胞路徑，並影響生理過程。據報導，Blarcamesine 在高奈米莫耳範圍內與 sigma-1 受體結合，在低微莫耳範圍內與毒蕈鹼受體結合。據報道，這種化合物在接受毒蕈鹼受體拮抗劑東莨菪鹼、合成 AB寡聚物注射液和 NMDA 受體促效劑地佐西平治療的小鼠中表現出記憶保留和神經保護作用（Villard 等） AB 使用寡聚物注射模型的其他研究表明，Blarcamesine可能抑制Tau過度磷酸化並保護粒線體。

市場動態：.

政府批准的增加預計將在預測期內推動市場成長。例如，2023年12月19日，開發治療神經退化性疾病和神經發育障礙的差異化療法的臨床階段生物製藥公司Anavex Lifesciences宣布，歐洲藥品管理局（European Medicines Agency）人類使用醫藥產品委員會（ EMA 內的CHMP）宣布，已同意用於治療阿茲海默症的口服 Blarcamesine 有資格根據歐洲藥品管理局的集中程序在歐盟提交行銷核准申請。

本研究的主要特點

本報告對全球 Bracamesin 市場進行了詳細分析，並介紹了以2023年為基準年的預測期（2026-2031）的市場規模和年複合成長率（CAGR %）。
揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球 Blarcamesine 市場的主要企業。
本報告的見解將使行銷人員和公司負責人能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球Blarcamesine市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進入者和財務分析師。
相關人員可以透過分析全球Blarcamesine市場時所使用的各種策略矩陣來促進決策。

北美洲
美國
加拿大
歐洲
德國
英國
西班牙
法國
義大利
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
澳洲
韓國
ASEAN
其他亞太地區
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
北非
中部非洲
南非

第9章競爭格局

公司簡介
- Anavex Life Sciences

第10章

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI6655

Global blarcamesin market will be valued at US$ 822.2 Mn in 2026 and is expected to reach US$ 992.4 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 3.8% from 2026 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 822.2 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2026 to 2031.
Forecast Period 2023/2024 to 2030/2031 CAGR:	3.80%	2030/2031 Value Projection:	US$ 992.4 Mn

Figure 1. Global Blarcamesine Market Share (%), By Region, 2026

Blarcamesine is an agonist of the intracellular sigma-1 chaperone protein. Specifically, it is a mixed ligand for sigma1/muscarinic receptors. Expressed in most tissues and located at focal contacts between mitochondria and the endoplasmic reticulum, the sigma-1 receptor forms heterodimers with many other membrane receptors and, as such, influences multiple cellular pathways and physiological processes. Blarcamesine reportedly binds the sigma-1 receptor in the high nanomolar and the muscarinic receptor in the low micromolar range. The compound has been reported to have memory-preserving and neuroprotective effects in mice treated with the muscarinic receptor antagonist scopolamine, with synthetic AB oligomer injection, or with the NMDA receptor agonist dizocilpine (Villard et al., 2011). Other studies in the AB oligomer injection model suggest that blarcamesine may block tau hyperphosphorylation and protect mitochondria.

Market Dynamics:

Increasing government approval is expected to drive the growth of the market over the forecast period. For instance, on December 19, 2023, Anavex Life Sciences, a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders, announced that the Committee for Medicinal Products for Human Use (CHMP) within the European Medicines Agency (EMA) agreed that oral blarcamesine for Alzheimer's disease is eligible for submission of an application for a Union Marketing Authorization in the EU under the European Medicines Agency's centralized procedure.

Key features of the study:

This report provides in-depth analysis of the global blarcamesine market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2026-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global blarcamesine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Anavex Life Sciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global blarcamesine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blarcamesine market

Detailed Segmentation:

Global Blarcamesine Market, By Route of Administration
- Oral
- Parentral
Global Blarcamesine Market, By Application
- Alzheimer's Disease
- Parkinson's Disease
- Dementia
- Rett Syndrome
- Others
Global Blarcamesine Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Blarcamesine Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Top Companies in the Global Blarcamesine Market:
- Anavex Life Sciences

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Blarcamesine Market, By Route of Administration
- Global Blarcamesine Market, By Application
- Global Blarcamesine Market, By Distribution Channel
- Global Blarcamesine Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing research and development activities
- Strict regulatory requirements
- Emerging markets
Key Highlights
Regulatory Scenario
Recent Trends
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Blarcamesine Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Blarcamesine Market, By Route of Administration, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024 and 2031(%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

6. Global Blarcamesine Market, By Application, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024 and 2031(%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Alzheimer's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Parkinson's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Dementia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Rett Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

7. Global Blarcamesine Market, By , 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024 and 2031(%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

8. Global Blarcamesine Market, By Region, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031(%)
- Y-o-Y Growth Analysis, For Region,
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Mn)
North Africa
Central Africa
South Africa